Molecular Vision: Kuiper, Mol Vis 2013; 19:2606-2614. Table 1

Table 1. Demographic information of patients in this study.

Patient	Age	Gender	Year of Diagnosis	Disease status		Current Treatment	Cataract or aphakic/ pseudophakic	Comorbidity
Patients with active disease naïve to immunomodulatory therapy
1	63	f	2011	active	-	-	-
2	68	f	2009	active	-	-	-	hypothyroidism
3	54	f	2011	active	-	-	-
4	74	m	2009	active	-	-	-	Diabetes
5	57	f	2011	active	-	-	-
Patients with inactive disease and/or current or past history (<6 months) of immunomodulatory therapy
6	68	f	2004	inactive	Corticosteroids Methotrexate	Methotrexate	+
7	63	f	2000	inactive	Corticosteroids Methotrexate	Methotrexate	+	hypothyroidism
8	56	f	2006	active	Corticosteroids Methotrexate	Mycophenolate mofetil	-	hypothyroidism
9	61	f	1994	active	Corticosteroids Methotrexate Cyclosporine	Mycophenolate mofetil	+
10	52	f	2008	inactive	Methotrexate	Methotrexate	+
11	61	m	2010	inactive	Methotrexate	Methotrexate	-
12	71	f	1993	inactive	Corticosteroids Methotrexate	Methotrexate	+
13	53	f	2000	inactive	Methotrexate	-	+
14	68	f	2004	inactive	Corticosteroids Methotrexate azathioprine	Methotrexate	+
15	66	f	1992	inactive	Corticosteroids	Methotrexate	+	Multiple-sclerosis
16	58	f	2006	inactive	Corticosteroids Methotrexate	Methotrexate	+
17	58	f	2007	inactive	Methotrexate	Adalimumab Corticosteroids	-
18	50	f	2007	inactive	Corticosteroids Methotrexate Mycophenolate mofetil	Methotrexate	+
19	66	f	2011	inactive	Mycophenolate mofetil	-	+	Mamacarcinoma hypothyroidism